Waite L C, Lineberry M D
Res Commun Chem Pathol Pharmacol. 1978 Mar;19(3):403-16.
The effects of phentolamine on calcium and phosphate metabolism were studied in young female rats. The i.p. administration of phentolamine (1.3 to 35.1 mg/kg) produces hypocalcemic and hypophosphatemic responses that resemble those produced by the hormone calcitonin. The hypocalcemic response to phentolamine reaches a maximum one hour post injection and blood calcium concentrations return to normal three hours following drug administration. Bilateral nephrectomy does not negate the hypocalcemic effect of phentolamine indicating that the drug effect is not mediated by increased renal excretion of calcium. Thyroparathyroidectomy inhibits the hypocalcemic activity of phentolamine. The mechanism of action of phentolamine with respect to changes in circulating calcium does not involve alpha adrenergic receptor blockage since large doses of tolazoline do not result in alterations in the plasma concentration of calcium. Labeling experiments with 45Ca indicate that the administration of phentolamine results in an inhibition of bone resorption.
在幼年雌性大鼠中研究了酚妥拉明对钙和磷代谢的影响。腹腔注射酚妥拉明(1.3至35.1毫克/千克)会产生低钙血症和低磷血症反应,类似于激素降钙素所产生的反应。对酚妥拉明的低钙血症反应在注射后1小时达到最大值,给药后3小时血钙浓度恢复正常。双侧肾切除并不能消除酚妥拉明的低钙血症作用,表明该药物作用不是由钙的肾脏排泄增加介导的。甲状腺甲状旁腺切除术会抑制酚妥拉明的低钙血症活性。酚妥拉明对循环钙变化的作用机制不涉及α肾上腺素能受体阻断,因为大剂量的妥拉唑啉不会导致血浆钙浓度改变。用45Ca进行的标记实验表明,酚妥拉明的给药会导致骨吸收受到抑制。